LCB 97
Alternative Names: LCB-97Latest Information Update: 30 Jun 2023
At a glance
- Originator LegoChem Biosciences
- Class Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 14 Apr 2023 Early research in Solid tumours in South Korea (Parenteral) prior to June 2023 (LegoChem Biosciences pipeline, June 2023)
- 14 Apr 2023 Preclinical trials in Solid tumours in South Korea (Parenteral)
- 14 Apr 2023 Initial pharmacodynamics data from a preclinical trial in Solid tumours presented at the 114th Annual Meeting of the American Association for Cancer Research (AACR-2023)